About Wellthy Therapeutics
Wellthy Therapeutics is a company based in Mumbai (India) founded in 2015 by Prayat Shah and Sneha Shah was acquired by TruDoc in February 2024. Wellthy Therapeutics has raised $8.91 million across 6 funding rounds from investors including India Infoline, IIFL Finance and Bayer. The company has 38 employees as of March 31, 2024. Wellthy Therapeutics offers products and services including Digital Care Operating System and Type 2 Diabetes Management App. Wellthy Therapeutics operates in a competitive market with competitors including DarioHealth, Welldoc, Pear Therapeutics, Spiras Health and Ciba Health, among others.
- Headquarter Mumbai, India
- Employees 38 as on 31 Mar, 2024
- Founders Prayat Shah, Sneha Shah
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wellthy Therapeutics Private Limited
- Date of Incorporation 02 Dec, 2015
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$501.33 K (USD)26.85as on Mar 31, 2022
-
Net Profit
-$1.6 M (USD)10.96as on Mar 31, 2022
-
EBITDA
-$1.62 M (USD)6.32as on Mar 31, 2022
-
Total Equity Funding
$8.91 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
India Infoline
& 25 more
-
Employee Count
38
as on Mar 31, 2024
-
Acquired by
TruDoc
(Feb 12, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wellthy Therapeutics
Wellthy Therapeutics offers a comprehensive portfolio of products and services, including Digital Care Operating System and Type 2 Diabetes Management App.
Enables digital solutions for chronic disease management and outcomes tracking
Assists in diet, exercise, and blood sugar control for patients
People of Wellthy Therapeutics
Unlock access to complete
Funding Insights of Wellthy Therapeutics
Wellthy Therapeutics has successfully raised a total of $8.91M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Wellthy Therapeutics
Wellthy Therapeutics has secured backing from 26 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include India Infoline, IIFL Finance and Bayer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Locked | Locked | Locked | |
|
Venture capital investments and partnerships in diverse sectors.
|
Locked | Locked | Locked | |
|
Early-stage venture capital fund
|
Locked | Locked | Locked |
Investor details for Wellthy Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wellthy Therapeutics
Investment portfolio details for Wellthy Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Wellthy Therapeutics
Detailed financials for Wellthy Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wellthy Therapeutics Comparisons
Peer comparison for Wellthy Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wellthy Therapeutics
Wellthy Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DarioHealth, Welldoc, Pear Therapeutics, Spiras Health and Ciba Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chronic conditions are managed via a personalized digital platform.
|
|
| Locked | Locked | Locked |
Mobile health products for chronic disease management are offered.
|
|
| Locked | Locked | Locked |
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
|
|
| Locked | Locked | Locked |
Asthma and COPD symptoms are managed through clinical services.
|
|
| Locked | Locked | Locked |
Provider of teleconsultation and digital therapeutic software for employees and patients
|
Detailed competitors of Wellthy Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wellthy Therapeutics
Complete news archive for Wellthy Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wellthy Therapeutics
Wellthy Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Wellthy Therapeutics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Wellthy Therapeutics is a funded company, having raised a total of $8.91M across 6 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Wellthy Therapeutics is 38.
Annual revenue of Wellthy Therapeutics is $501.33K as on Mar 31, 2022.
Wellthy Therapeutics was founded in 2015 in Mumbai, India, within the health technology sector. A platform is offered that integrates with smart devices to track vital signs of patients with chronic conditions, including diabetes, hypertension, heart failure, and chronic kidney disease. Health data is visualized remotely by providers and caregivers. Lifestyle management programs are provided for chronic disease support, alongside a dashboard for monitoring patient progress.
Wellthy Therapeutics's top competitors include Welldoc, DarioHealth and Ciba Health.
Wellthy Therapeutics offers Digital Care Operating System and Type 2 Diabetes Management App.
Wellthy Therapeutics has 26 investors. Key investors include India Infoline, IIFL Finance, Bayer, Manipal Group, and Cipla.
The valuation of Wellthy Therapeutics is $25.37M as of Apr 2021.